Vector-borne diseases (VBDs) pose a significant public health challenge in India, affecting millions annually. The country's diverse ecosystem and climatic conditions provide an ideal environment for the proliferation of various vectors, leading to the widespread prevalence of these diseases.
VBDs, including malaria, dengue, and chikungunya, account for more than 17% of all infectious diseases in India, causing substantial morbidity and mortality. The economic burden induced by VBDs is considerable, with direct and indirect costs affecting both the healthcare system and the affected individuals.
Despite several control measures, the elimination of VBDs remains a formidable challenge due to factors such as inadequate surveillance, lack of public awareness, and socio-economic disparities. Additionally, climate change and urbanization contribute to the increased incidence and geographical spread of these diseases.
Healthcare professionals play a crucial role in combating VBDs through early diagnosis, appropriate treatment, and patient education. They are instrumental in implementing preventive measures, conducting research, and advocating for policy changes to mitigate the impact of these diseases.
In conclusion, the burden of VBDs in India is significant and complex, necessitating a multi-faceted approach for effective control. Healthcare professionals are at the forefront of this battle, and their role is pivotal in reducing the disease burden. Continued efforts towards improving surveillance, enhancing public awareness, and fostering research and development are essential to tackle the challenge of VBDs in India.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation